Commentary on the model Trustees’ Annual Report and Accounts:
Triumph for Tomas (T4T).
T4T had no external activity during this time period due to trustee commitments elsewhere due to the cost of living crisis. We however had to maintain our website and Office 365 subscriptions with a total deduction for the year of (£562), leaving a balance for FY23/24 of £10,081
.
## **Triumph for Tomas**
## **Report of the trustees for the year ending 31[st] March 2018.**
The trustees at T4T present their annual report and accounts for the year end 31[st] March 2019.
## **Our Aim**
Our aim is simple, we want to provide factual information to families who have been given PMD as a diagnosis. Enable them to connect with other families and share stories, milestones, advice and feel less isolated and scared.
## **Our Objective**
The object of Triumph for Tomas is the promotion and protection of good health among people suffering from Pelizaeus-Merzbacher Disease (PMD) and gene-linked disorders known as the leukodystrophies, characterised by myelin sheath abnormalities, in particular but not exclusively by providing information, advice, practical support and grants of financial assistance to such people and their families and carers.
## **Review of Activities and Achievements**
FY18/19 has generated a loss for T4T of £350 once all receipts and payments have been accounted for. T4T did have a disappointing year of activities, however given the minimal global population affected by the conditions we support we do not expect to see large jumps annually. We had a meeting during FY18/19 and discussed our focus for the coming FY19/20 and a real focus on what will help those who can gain support from T4T.
## **Financial Review**
FY18/19 all relevant information can be found on our charity accounts CC16a.
**Triumph for Tomas**
**----- Start of picture text -----**
1166810
**----- End of picture text -----**
||||**Receipts andpayments accounts**|**Receipts andpayments accounts**|**Receipts andpayments accounts**|**Receipts andpayments accounts**|**Receipts andpayments accounts**|**Receipts andpayments accounts**|**Receipts andpayments accounts**|**Receipts andpayments accounts**|**Receipts andpayments accounts**|**ments accounts**|**ments accounts**|**ments accounts**|**ments accounts**|**ments accounts**||||**CC16a**|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
||||**For the period**
**from**
~~es~~||||Period start date
2/6/2023
~~ee~~||||**To**|Period end date
1/6/2024
~~eee~~|||||||||
||**Section A Receipts and payments**
~~ne~~||||||||||||||||||||
||||**Unrestricted**
**funds**||||**Restricted**
**funds**||||**Endowment**
**funds**|||||**Total funds**||||**Last year**|
||||**to the nearest £**||||**to the nearest £**||||**to the nearest £**|||||**to the nearest £**||||**to the nearest £**|
||**A1 Receipts**||||||||||||||||||||
||CharityTub Donations||||||**-**||||**-**|**-**||||**-**||||**-**|
||||**-**||||**-**||||**-**|**-**||||**-**||||**-**|
||||||||**-**||||**-**|**-**||||**-**||||**-**|
||||||||**-**||||**-**|**-**||||**-**|||||
||||||||**-**||||**-**|**-**||||**-**||||**-**|
||||||||**-**||||**-**|**-**||||**-**||||**-**|
||||**-**||||**-**||||**-**|**-**||||**-**||||**-**|
||||**-**||||**-**||||**-**|**-**||||**-**||||**-**|
||||**-**||||**-**||||**-**|**-**||||**-**||||**-**|
||**_Sub total_**_(Gross income for AR)_|_(Gross income for AR)_|_(Gross income for AR)_||||||||||||||||||
|**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**_Sub total_ -**
**-**
**-**
**-**
**-**
**_Total receipts_ -**
**-**
**-**
**-**
**-**
**A2 Asset and investment sales,**
**(see table).**
~~————=~~|||||||||||||||||||||
||**A3 Payments**||||||||||||||||||||
|Postage & Sundries
**-**
Windows 365 Subscription
**179**
Website Upkeep
**383**
~~Se~~|||||||**-**
**-**
**-**||||**-**
**-**
**-**|**-**
**-**
**-**||||**-**
**179**
**383**||||**-**
**-**
**-**|
CCXX R1 accounts (SS)
07/19/2025
1
||||**-**||**-**||**-**||**-**|
|---|---|---|---|---|---|---|---|---|---|
||||**-**||**-**||**-**||**-**|
||**-**||**-**||**-**||**-**||**-**|
||**-**||**-**||**-**||**-**||**-**|
||**-**||**-**||**-**||**-**||**-**|
||**-**||**-**||**-**||**-**||**-**|
|**_Sub total_**|**562**||**-**||**-**||**562**||**-**|
|**A4 Asset and investment**|||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|**purchases, (see table)**|||||||||||||||||||||||
|||**-**|||||**-**|||||**-**||||**-**|||||||
|||**-**|||||**-**|||||**-**||||**-**|||||||
|**_Sub total_**||**-**|||||**-**|||||**-**||||**-**|||||**-**||
||||||||||||||||||||||||
|**_Total payments_ **||**562**|||||**-**|||||**-**||||**562**|||||**-**||
||||||||||||||||||||||||
|**_Net of receipts/(payments)_ **||**- 562**||||**-**|||||**-**|||||**- 562**||||**-**|||
|**A5 Transfers between funds**||**-**||||**-**|||||**-**|||||**-**||||**-**|||
|**A6 Cash funds last year end**||**-**||||**-**|||||**-**|||||**-**||||**-**|||
|**_Cash funds this year end_ **||**- 562**||||**-**|||||**-**|||||**- 562**||||**-**|||
||||||||||||||||||||||||
## **Section B Statement of assets and liabilities at the end of the period**
|**Categories**
**B1 Cash funds**|**Details**
Cash in Bank
**_Total cash funds_**
(agree balances with receipts and payments
account(s))|**to nearest £**
**10,081**
**-**
**10,081**
Agreement Error
**Unrestricted**
**funds**|**to nearest £**
**-**
**-**
**-**
**-**
OK
**Restricted**
**funds**|**to nearest £**
**Endowment**
**funds**|
|---|---|---|---|---|
|||||**-**|
|||||**-**|
|||||**-**|
|||||**-**|
|||||OK|
CCXX R2 accounts (SS)
07/19/2025
2
|**B2 Other monetary assets**
**B3 Investment assets**|**Details**|**to nearest £**
**-**
**-**
**-**
**-**
**-**
**-**
**Unrestricted**
**funds**|**to nearest £**
**-**
**-**
**-**
**-**
**-**
**-**
**Restricted**
**funds**|**to nearest £**
**Endowment**
**funds**|
|---|---|---|---|---|
|||||**-**|
|||||**-**|
|||||**-**|
|||||**-**|
|||||**-**|
|||||**-**|
||||||
||**Details**|**Fund to which**
**asset belongs**|**Cost (optional)**
**-**
**-**
**-**
**-**
**-**|**Current value**
**(optional)**|
||||**-**|**-**|
||||**-**|**-**|
||||**-**|**-**|
||||**-**|**-**|
||||**-**|**-**|
||**Details**|**Fund to which**
**asset belongs**|**Cost (optional)**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**|**Current value**
**(optional)**|
||||**-**|**-**|
||||**-**|**-**|
||||**-**|**-**|
||||**-**|**-**|
||||**-**|**-**|
||||**-**|**-**|
||||**-**|**-**|
||||**-**|**-**|
||**Details**||**Fund to which**
**asset belongs**||**Cost (optional)**||**Current value**
**(optional)**||
|---|---|---|---|---|---|---|---|---|
||||||**-**|||**-**|
||||||**-**|||**-**|
||||||**-**|||**-**|
||||||**-**|||**-**|
||||||**-**|||**-**|
||**Details**||**Fund to which**
**asset belongs**||**Cost (optional)**||**Current value**
**(optional)**||
||||||**-**|||**-**|
||||||**-**|||**-**|
||||||**-**|||**-**|
||||||**-**|||**-**|
||||||**-**|||**-**|
||||||**-**|||**-**|
||||||**-**|||**-**|
||||||**-**|||**-**|
## **B4 Assets retained for the charity’s own use**
CCXX R3 accounts (SS)
07/19/2025
3
## **B5 Liabilities**
Signed by one or two trustees on behalf of all the trustees
||||||**-**||**-**|
|---|---|---|---|---|---|---|---|
||||**Fund to which**||**Amount due**||**When due**|
||**Details**||**liability relates**||**(optional)**||**(optional)**|
||||||**-**|||
||||||**-**|||
||||||**-**|||
||||||**-**|||
||||||**-**|||
||Signature||Print|Name|||Date of
approval|
||M D Powell||Matthew||Powell||14.08.24|
||E L Powell||Emma Powell|||||
||||||||**14.08.24**|
CCXX R4 accounts (SS)
07/19/2025
4